Cassava Sciences, Inc. (NASDAQ:SAVA) Q3 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, welcome to Cassava Sciences Report for the Third Quarter 2024. At this time, all participants are in a listen-only mode.
Cassava Sciences Inc (SAVA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 527,200 | $15,515,496 | +692% | 0% | |
| 2. | 493,200 | $14,514,876 | +396% | 0% | |
| 3. | 489,800 | $14,414,814 | -9% | 0.11% | |
| 4. | 411,000 | $12,095,730 | +108% | 0.09% | |
| 5. | 183,000 | $5,385,690 | 0.11% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.45 | 30,000 | Director | 886,851 | 2023-08-23 | Filing | |
| $16.65 | 16,571 | Director | 293,477 | 2023-08-22 | Filing | |
| $16.80 | 1,906 | Director | 276,906 | 2023-08-21 | Filing | |
| $25.76 | 77,276 | Director | 275,000 | 2023-03-07 | Filing | |
| $26.13 | 11,565 | Director | 197,724 | 2023-03-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 0 | Large Shareholder | 0 | 2018-10-03 | Filing | |
| $0.00 | 0 | Large Shareholder | 0 | 2018-10-03 | Filing | |
| $1.31 | 512,660 | Large Shareholder | 1,651,340 | 2018-10-03 | Filing | |
| $0.00 | 0 | Large Shareholder | 2,164,000 | 2018-08-20 | Filing | |
| $0.00 | 0 | Large Shareholder | 2,164,000 | 2018-08-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,037,415 | $68,372,211 | 0% | |
| 2. | 2,324,626 | $52,327,331 | 0% | |
| 3. | 1,069,649 | $24,077,799 | 0% | |
| 4. | 1,013,200 | $22,807,132 | 0.05% | |
| 5. | 873,996 | $19,675,896 | 0% |
News See All
Jim Cramer's Latest Lightning Round: 12 Stocks to Watch
On Tuesday, Jim Cramer, host of Mad Money, shared his thoughts on the market's recent volatility and offered advice to investors regarding earnings reports.
7 Best Debt Free Stocks To Buy
Debt has always been the fuel driving many companies in the equity markets.
Cassava Sciences, Inc. (NASDAQ:SAVA) Q2 2024 Earnings Call Transcript
Operator: Welcome to Cassava Sciences Reports for the Second Quarter 2024. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation.
Jim Cramer’s Latest Stock Portfolio: Top 10 Recommendations
Jim Cramer in a latest program talked about the concept of “suitability” of stocks in investing, which emphasizes the importance of picking individual stocks based on your personal context, circumstances...
5 Most Promising Small-Cap Stocks According to Analysts
In this piece, we will take a look at the five most promising small-cap stocks according to analysts.
16 Most Shorted Stocks Right Now
One of the most intriguing plays on the stock market is short selling. This is because it goes against conventional investment logic, which typically seeks to profit from an increase in share prices.
Hedge Fund and Insider Trading News: George Soros, Ray Dalio, Crispin Odey, Three Arrows Capital (3AC), Cassava Sciences Inc (SAVA), AN2 Therapeutics, Inc. (ANTX), and More
Bridgewater Associates founder says India successfully landing Chandrayaan-3 on the moon is "another one of many straws in the wind showing its ascendence".
Top 5 Small-Cap Stocks With Highest Upside Potential
In this piece, we will take a look at the top five small-cap stocks with the highest upside potential.
Hedge Fund and Insider Trading News: Miller Value Partners, Millennium Management, Taiga Fund, Three Arrows Capital, DISH Network Corp (DISH), Moderna Inc (MRNA), and More
Izzy Englander’s Millennium Management has changed its terms to ensure that clients always pay a minimum fee, even if the hedge fund loses money.
Billionaire Hedge Funds
